Showing results 1 to 5 of 5
Title | Author(s) | Issue Date | |
---|---|---|---|
DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control Journal:BMJ Open Diabetes Research & Care | 2020 | ||
2018 | |||
Switching to Versus Addition of Incretin‐Based Drugs Among Patients With Type 2 Diabetes Taking Sodium‐Glucose Cotransporter‐2 Inhibitors Journal:Journal of the American Heart Association | 2022 | ||
2022 | |||
Treatment intensification with Dipeptidylpeptidase-4 inhibitor, insulin, or Thiazolidinediones and risks of cardiovascular diseases and all-cause mortality in patients on metformin-sulfonylurea dual therapy Proceeding/Conference:14th International Symposium on Healthy Aging, 2019 | 2019 |